SCHEMBL1773385

SCHEMBL1773385

CCCCCCCCC(C)(O)O

nearest known ligand 0.50

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
FDPS P14324 10/20 0.50
GGPS1 O95749 7/20 0.50
TSHR P16473 1/20 0.47
THRB P10828 1/20 0.47
SMPD1 P17405 1/20 0.45
CES2 O00748 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3676528 1.00 FDPS (0.50) FDPSGGPS1TSHRTHRBSMPD1
SCHEMBL28791865 1.00 FDPS (0.50) FDPSGGPS1TSHRTHRBSMPD1
SCHEMBL30787151 1.00 FDPS (0.50) FDPSGGPS1TSHRTHRBSMPD1
SCHEMBL29266178 1.00 FDPS (0.50) FDPSGGPS1TSHRTHRBSMPD1
SCHEMBL30787432 1.00 FDPS (0.50) FDPSGGPS1TSHRTHRBSMPD1
SCHEMBL15155875 1.00 FDPS (0.50) FDPSGGPS1TSHRTHRBSMPD1
SCHEMBL24761603 1.00 FDPS (0.50) FDPSGGPS1TSHRTHRBSMPD1
SCHEMBL226634 1.00 FDPS (0.50) FDPSGGPS1TSHRTHRBSMPD1
SCHEMBL7865459 1.00 FDPS (0.50) FDPSGGPS1TSHRTHRBSMPD1
SCHEMBL27808460 1.00 FDPS (0.50) FDPSGGPS1TSHRTHRBSMPD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 109 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017143132-A1 ALKYL DIOLS FOR CRUDE OIL TREATMENT ECOLAB USA INC. (US) 2017-08-24 WO claimed
US-6899753-B2 Highly bleed-alleviating ink composition BENQ CORPORATION (TW) 2005-05-31 US claimed
US-20030037700-A1 Highly bleed-alleviating ink composition MIND FUSION, LLC 2003-02-27 US claimed
EP-1239896-A1 ANTICALCIFICATION TREATMENTS FOR FIXED BIOMATERIALS Sulzer Carbomedics Inc. (US) 2002-09-18 EP claimed
WO-2001041828-A1 ANTICALCIFICATION TREATMENTS FOR FIXED BIOMATERIALS SULZER CARBOMEDICS INC. (US) 2001-06-14 WO claimed
US-20260071379-A1 TEXTILE TREATMENT COMPOSITION FOR ANTI-YELLOWING SYMRISE AG (DE) 2026-03-12 US disclosed
EP-4706780-A2 COMPOSITIONS COMPRISING UV-FILTERS AND ONE OR MORE (BIO)-ALKANEDIOLS Symrise AG (DE) 2026-03-11 EP disclosed
EP-4110276-B1 COMPOSITIONS COMPRISING ALKANEDIOLS SYMRISE AG (DE) 2026-01-28 EP disclosed
EP-4616840-A2 COMPOSITIONS COMPRISING (BIO)-ALKANEDIOLS WITH ANTIMICROBIALS FOR PRODUCT PROTECTION Symrise AG (DE) 2025-09-17 EP disclosed
EP-4608951-A1 TEXTILE TREATMENT COMPOSITION FOR ANTI-YELLOWING Symrise AG (DE) 2025-09-03 EP disclosed
EP-4608952-A1 DETERGENT AND/OR CLEANING COMPOSITIONS FOR MALODOR REDUCTION AND FRAGRANCE BOOST Symrise AG (DE) 2025-09-03 EP disclosed
US-20250255833-A1 Compositions Comprising One or More (Bio)-Alkanediols with Antioxidants SYMRISE AG (DE) 2025-08-14 US disclosed
US-8431195-B2 Ink composition for printing, paper container material using the ink composition, and heat insulating foamed paper container NISSIN FOODS HOLDINGS CO., LTD. (JP) 2013-04-30 US disclosed
CN-101519552-B Method for preparing inkjet water-soluble ink containing noble metal nano particles CHINESE ACAD INST CHEMISTRY 2011-08-24 CN disclosed
US-20110111150-A1 BRIGHTENING INK COMPOSITION FOR PRINTING, PAPER CONTAINER MATERIAL USING THE BRIGHTENING INK COMPOSITION, AND HEAT INSULATING FOAMED PAPER CONTAINER NISSIN FOODS HOLDINGS CO., LTD. (JP) 2011-05-12 US disclosed
US-20110101083-A1 INK COMPOSITION FOR PRINTING, PAPER CONTAINER MATERIAL USING THE INK COMPOSITION, AND HEAT INSULATING FOAMED PAPER CONTAINER NISSIN FOODS HOLDINGS CO., LTD. (JP) 2011-05-05 US disclosed
CN-101519552-A Method for preparing inkjet water-soluble ink containing noble metal nano particles CHINESE ACAD INST CHEMISTRY 2009-09-02 CN disclosed
US-6899753-B2 Highly bleed-alleviating ink composition BENQ CORPORATION (TW) 2005-05-31 US disclosed
CN-1401710-A Ink composition with high ink bleeding prevention BENQ CORP (CN) 2003-03-12 CN disclosed
US-20030037700-A1 Highly bleed-alleviating ink composition MIND FUSION, LLC 2003-02-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250255833-A1 Compositions Comprising One or More (Bio)-Alkanediols with Antioxidants MMP8, CXCL8, IL18 FDPS 4423/4885GGPS1 4186/4885TSHR 4555/4885
US-20260071379-A1 TEXTILE TREATMENT COMPOSITION FOR ANTI-YELLOWING PON1, ACHE, TPSB2 FDPS 3554/4885GGPS1 1052/4885TSHR 4646/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.